I love the potential that this company is exhibiting.

It’s still early-stage for it, but in the past three weeks, we’ve been able to see why their management team is considered the most prudent in the industry.


Here’s the bottom line on this pick.

  1. Greece: Thanks to management, shareholders now control the only government-issued cultivation and production license in the country!

With this, they can export to other EU-member nations. The best way to look at it is as a main hub in a country that enjoys outstanding sunshine climate conditions.

This will give this stock a running start, as competitors later follow it into this jurisdiction.

  1. South Africa: CanAfrica holds a license to cultivate, manufacture, supply, hold, import, export and transport cannabis products.

It has an ideal climate for low-cost greenhouse cannabis production.

AriCannabis has agreements in place to provide cannabis products to over 2,800 independent and corporate pharmacies across South Africa.

Both ariCannabis and CanAfrica are subsidiaries of our top-ranked opportunity, ICC Intl Cannabis (CSE: WRLD & US: KNHBF).

On September 18, South Africa’s Constitutional Court unanimously voted to legalize adult cannabis consumption, as well as the cultivation of cannabis for private consumption.

  1. Colombia: Cannabis Medical Group SAS, a Colombian entity, holds licenses to cultivate, produce, hold, sell and export cannabis.

This is another holding of ICC Intil (US: KNHBF). 

It has already acquired 13 hectares of optimal agricultural land located in Funza, the heart of the Bogota savanna, which is also one of the safest areas in Colombia.

93% Of Investors Generate Annual Returns, Which Barely Beat Inflation.

Wealth Education and Investment Principles Are Hidden From Public Database On Purpose!

Build The Knowledge Base To Set Yourself Up For A Wealthy Retirement and Leverage The Relationships We Are Forming With Proven Small-Cap Management Teams To Hit Grand-Slams!

    Colombia is gearing-up, economically speaking, to become an important export hub for quality cannabis.

    On top of these, the Danish subsidiary is building a truly modern facility, which complies with the highest standards of regulatory bodies in Europe, which will provide a major boost as well.

    I’ve yet to see any cannabis company spread operation so wisely, planting seeds in such a strategically savvy manner.

    The two wild cards, which can turn into the company’s most promising revenue generators, are:

    1. Global Marathon: With an exclusive agreement with Cosmos Holdings, a European based pharmaceutical distributor, to procure and distribute medical cannabis products, for clients of Cosmos in approved countries within its distribution network, this is a critical agreement for shareholders.

    This comprises of 110 clients, representing approximately 35,000 pharmacies in 16 countries. These are, what we call, game-changing potential deals flow.

    1. BioCanna ADM: This retail system is an intelligent automated retail kiosk for the dispensing of cannabis, in both medical and commercial markets.

    The BioCanna ADM retail system offers a solution to many of the concerns relating to controlling the access of properly identified and qualified client, solely.

    The proprietary software system, which operates the BioCanna ADM, offers regulatory bodies the ability to dynamically observe transactions in real-time at every Kiosk located within their legal jurisdiction. No one can copy this Intellectual Property!


    Best Regards,

    Tom Beck
    Research Partner,

    Protect Yourself Now, By Building A Fully-Hedged Financial Fortress!

    Governments Have Amassed ungodly Debt Piles and Have Promised Retirees Unreasonable Amounts of Entitlements, Not In Line with Income Tax Collections. The House of Cards Is Set To Be Worse than 2008! Rising Interest Rates Can Topple The Fiat Monetary Structure, Leaving Investors with Less Than Half of Their Equity Intact!

      Legal Notice:

      This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

      Please read our full disclaimer at

      Gold Stocks. Every Extra Word is Unnecessary

      Gold Stocks. Every Extra Word is Unnecessary

      Gold has never closed a calendar month at a higher price in USD terms, but CNBC didn’t even spend 10 seconds on this topic, and I want to thank the propaganda machine at the editorial studio for continuing not to mention what’s happening in the real world.

      read more